NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 34 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,462,361 | +20.9% | 5,132,000 | +24.2% | 0.30% | +41.1% |
| Q4 2022 | $3,690,946 | -37.0% | 4,132,000 | -37.6% | 0.21% | -24.3% |
| Q3 2022 | $5,860,000 | -21.9% | 6,617,000 | -23.2% | 0.28% | -9.8% |
| Q2 2022 | $7,508,000 | -39.6% | 8,617,000 | -36.5% | 0.31% | -32.0% |
| Q1 2022 | $12,426,000 | – | 13,560,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 134,334,000 | $116,802,148 | 3.85% |
| STEELHEAD PARTNERS LLC | 46,562,000 | $40,485,659 | 2.64% |
| DeepCurrents Investment Group LLC | 40,000,000 | $34,578,496 | 1.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $66,300,852 | 0.78% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,317,000 | $9,786,521 | 0.74% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,856,000 | $4,199,900 | 0.62% |
| Ionic Capital Management LLC | 2,000,000 | $1,726,349 | 0.50% |
| Empyrean Capital Partners, LP | 15,000,000 | $12,980,000 | 0.44% |
| Context Capital Management, LLC | 4,489 | $3,903 | 0.33% |
| Graham Capital Management, L.P. | 11,422,000 | $9,875,746 | 0.30% |